Amerigo Scientific introduces integrated 3D bioprinting ecosystem for the laboratory

Amerigo Scientific is expanding its life science portfolio with a product line for 3D bioprinting. The offering includes extrusion-based 3D bioprinters as well as matching bioinks and additional biomaterials. The target group is research institutions that want to generate complex tissue structures and 3D models that are physiologically more relevant than classical 2D cultures.

At the core of the platform are bioprinters designed for operation in standard laboratory environments and supporting various printheads and cartridge systems. The systems use pneumatically or screw-driven controlled extrusion to deposit delicate cell aggregates, hydrogels or microcarriers at a defined flow rate. According to the manufacturer, multiple materials can be combined within a single print job, such as synthetic polymers, cell-containing bioinks and supporting scaffold materials, to create heterogeneous tissue and interface structures.

Complementing the hardware, Amerigo Scientific offers a portfolio of validated bioinks and biomaterials that, according to the company, have been tested in academic and industrial tissue engineering projects. The composition, viscosity and crosslinking chemistry of the materials are tailored to use in extrusion processes and are intended to enable reproducible mechanical properties as well as high cell viability.

“Our mission is to equip researchers with the innovative tools they need to make groundbreaking discoveries,” said a spokesperson for Amerigo Scientific. “By offering this integrated ecosystem of 3D bioprinters and complementary biomaterials, we are lowering the barrier to entry for complex 3D biology work and accelerating the path from basic research to therapeutic applications.”

On the application side, the product line primarily addresses the development of 3D models for drug screening, patient-specific scaffolds in regenerative medicine, and tumor models with a defined microenvironment for oncology. By combining finely controllable extrusion technology with specialized bioinks, prototypes ranging from simple test constructs to more functional tissue models can be produced iteratively within the same system. This positions Amerigo Scientific as a provider of an end-to-end bioprinting stack from cell culture through to the 3D model ready for printing.